Education
About Us
Working with TipRanks
Follow Us
NRGENE TECHNOLOGIES LTD (IL:NRGN)
:NRGN
NRGN Stock Chart & Stats
239.80
0.03(0.96%)
At close: 4:00 PM EST
239.80
0.03(0.96%)
Day’s Range― - ―
52-Week Range0.00 - 390.00
Previous CloseN/A
Volume1.26K
Average Volume (3M)27.56K
Market Cap
30.72M
Enterprise Value29.43M
Total Cash (Recent Filing)1.96M
Total Debt (Recent Filing)150.00K
Price to Earnings (P/E)―
Beta0.24
Next Earnings
Sep 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-40.30
Shares Outstanding13,224,474
10 Day Avg. Volume57,803
30 Day Avg. Volume27,561
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)2.10
Price to Sales (P/S)6.44
P/FCF Ratio-1.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NRGN FAQ
What was NRGENE TECHNOLOGIES LTD’s price range in the past 12 months?
NRGENE TECHNOLOGIES LTD lowest stock price was 0.00 and its highest was 390.00 in the past 12 months.
What is NRGENE TECHNOLOGIES LTD’s market cap?
NRGENE TECHNOLOGIES LTD’s market cap is 30.72M.
When is NRGENE TECHNOLOGIES LTD’s upcoming earnings report date?
NRGENE TECHNOLOGIES LTD’s upcoming earnings report date is Sep 02, 2025 which is 114 days ago.
How were NRGENE TECHNOLOGIES LTD’s earnings last quarter?
NRGENE TECHNOLOGIES LTD released its earnings results on Apr 01, 2025. The company reported -40.3 earnings per share for the quarter, missing the consensus estimate of N/A by -40.3.
Is NRGENE TECHNOLOGIES LTD overvalued?
According to Wall Street analysts NRGENE TECHNOLOGIES LTD’s price is currently Overvalued.
Does NRGENE TECHNOLOGIES LTD pay dividends?
NRGENE TECHNOLOGIES LTD does not currently pay dividends.
What is NRGENE TECHNOLOGIES LTD’s EPS estimate?
NRGENE TECHNOLOGIES LTD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NRGENE TECHNOLOGIES LTD have?
NRGENE TECHNOLOGIES LTD has 13,224,474 shares outstanding.
What happened to NRGENE TECHNOLOGIES LTD’s price movement after its last earnings report?
NRGENE TECHNOLOGIES LTD reported an EPS of -40.3 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.383%.
Which hedge fund is a major shareholder of NRGENE TECHNOLOGIES LTD?
Currently, no hedge funds are holding shares in IL:NRGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NRGENE TECHNOLOGIES LTD
Nrgene (NRGN) is a biotechnology company specializing in genomic analysis and bioinformatics solutions. The company primarily operates in the agricultural sector, focusing on enhancing crop yields and improving plant traits through advanced genomic technologies. Nrgene's core products include genomic data analysis services, software tools for genomic research, and proprietary algorithms that facilitate the breeding of superior plant varieties. By leveraging cutting-edge genomic technologies, Nrgene aims to support farmers and agricultural businesses in optimizing their production processes.